These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. Wolfe MS; Xia W; Moore CL; Leatherwood DD; Ostaszewski B; Rahmati T; Donkor IO; Selkoe DJ Biochemistry; 1999 Apr; 38(15):4720-7. PubMed ID: 10200159 [TBL] [Abstract][Full Text] [Related]
4. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373 [TBL] [Abstract][Full Text] [Related]
5. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease. Pollack SJ; Lewis H Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602 [TBL] [Abstract][Full Text] [Related]
6. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase. Sauder JM; Arthur JW; Dunbrack RL J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463 [TBL] [Abstract][Full Text] [Related]
7. gamma-Secretase as a target for drug intervention in Alzheimer's disease. Harrison T; Churcher I; Beher D Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873 [TBL] [Abstract][Full Text] [Related]
8. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages. Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514 [TBL] [Abstract][Full Text] [Related]
9. Identification of the multicatalytic enzyme as a possible gamma-secretase for the amyloid precursor protein. Mundy DI Biochem Biophys Res Commun; 1994 Oct; 204(1):333-41. PubMed ID: 7945379 [TBL] [Abstract][Full Text] [Related]
10. [Strategies for identification of secretases implicated in Alzheimer's disease]. Marambaud P; Chevallier N; Lopez-Perez E; Drouot C; Vizzanova J; Fulcrand P; Martinez J; Wilk S; Checler F Ann Biol Clin (Paris); 1998; 56(3):277-84. PubMed ID: 9754260 [TBL] [Abstract][Full Text] [Related]
11. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity. Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016 [No Abstract] [Full Text] [Related]
12. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054 [TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of Alzheimer's disease: implications from amyloid research front]. Iwatsubo T Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286 [TBL] [Abstract][Full Text] [Related]
16. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Zhou S; Zhou H; Walian PJ; Jap BK Proc Natl Acad Sci U S A; 2005 May; 102(21):7499-504. PubMed ID: 15890777 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of gamma-secretase inhibitors. Josien H Curr Opin Drug Discov Devel; 2002 Jul; 5(4):513-25. PubMed ID: 12197309 [TBL] [Abstract][Full Text] [Related]
18. Modulators and inhibitors of gamma- and beta-secretases. Schmidt B; Baumann S; Narlawar R; Braun HA; Larbig G Neurodegener Dis; 2006; 3(4-5):290-7. PubMed ID: 17047370 [TBL] [Abstract][Full Text] [Related]
19. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor. Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193 [TBL] [Abstract][Full Text] [Related]
20. gamma-Secretase can cleave amyloid precursor protein fragments independent of alpha- and beta-secretase pre-cutting. Kume H; Sekijima Y; Maruyama K; Kametani F Int J Mol Med; 2003 Jul; 12(1):57-60. PubMed ID: 12792809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]